Latest News-LUNIT INC Mediaroom_Page

Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study

* Lancet Digital Health study highlights Lunit INSIGHT CXR as top performer in TB screening, show...

2024-08-06 21:00 2431

Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study

Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program

* Middle East's first full-scale AI adoption for national screening marks Lunit's latest mileston...

2024-07-22 21:00 2947

Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program

Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response

- Lunit's ASCO 2024 presentations to highlight advances including HER2 ultra-low detection and AI-p...

2024-05-24 22:07 6124

Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response

Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care

SEOUL, South Korea, May 22, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-po...

2024-05-22 21:00 2596

Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care

Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite

- From research to real-world impact: Lunit demonstrates Lunit INSIGHT's clinical safety, effective...

2024-05-20 21:00 2641

Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite

Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals

- Employing Lunit INSIGHT MMG, a Turkish study showcases 70% efficiency improvements, advancements ...

2024-04-08 21:00 2445

Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals

Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification

- Lunit's AACR 2024 presentations to spotlight HER2 mutation insights and CNTN4's role in immunothe...

2024-04-01 21:00 2602

Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

- New research published in Clinical Cancer Research shows significant improvement in distant recur...

2024-03-26 21:00 1760

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

* New supply contract to bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to t...

2024-03-18 21:00 2577

Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research

- Lunit SCOPE HER2 and Lunit SCOPE ER/PR significantly improve pathologist concordance and accuracy...

2024-03-14 21:00 2442

Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research

Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured

- Volpara shareholder meeting to be held on April 12, 2024: Culminating the acquisition journey for...

2024-03-13 21:00 2333

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

- Lunit to unveil four oral presentations and three poster presentations at ECR 2024, highlighting ...

2024-02-28 22:03 1944

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC

- A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-po...

2024-02-16 22:03 5686

New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology

- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accura...

2023-11-22 22:07 2603

Latest News